TY  - GEN
AU  - De Botton,S
AU  - Dombret,H
AU  - Sanz,M
AU  - Miguel,J S
AU  - Caillot,D
AU  - Zittoun,R
AU  - Gardembas,M
AU  - Stamatoulas,A
AU  - Condé,E
AU  - Guerci,A
AU  - Gardin,C
AU  - Geiser,K
AU  - Makhoul,D C
AU  - Reman,O
AU  - de la Serna,J
AU  - Lefrere,F
AU  - Chomienne,C
AU  - Chastang,C
AU  - Degos,L
AU  - Fenaux,P
TI  - Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group
SN  - 0006-4971
PY  - 1998///1109
KW  - Acute Kidney Injury
KW  - chemically induced
KW  - Adult
KW  - Aged
KW  - Antibiotics, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Cardiovascular Diseases
KW  - Cytarabine
KW  - Dexamethasone
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Incidence
KW  - Leukemia, Promyelocytic, Acute
KW  - drug therapy
KW  - Leukocyte Count
KW  - drug effects
KW  - Life Tables
KW  - Male
KW  - Middle Aged
KW  - Pericardial Effusion
KW  - Pleural Effusion
KW  - Proportional Hazards Models
KW  - Remission Induction
KW  - Respiration Disorders
KW  - Survival Rate
KW  - Syndrome
KW  - Treatment Outcome
KW  - Tretinoin
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
ER  -